Olympus Corporation (OCPNF)
OTCMKTS · Delayed Price · Currency is USD
8.21
+0.21 (2.59%)
At close: Mar 12, 2026
Olympus Revenue
Olympus had revenue of 261.05B JPY in the quarter ending December 31, 2025, with 3.92% growth. This brings the company's revenue in the last twelve months to 987.51B, up 0.18% year-over-year. In the fiscal year ending March 31, 2025, Olympus had annual revenue of 997.33B with 6.53% growth.
Revenue (ttm)
987.51B JPY
Revenue Growth
+0.18%
P/S Ratio
1.51
Revenue / Employee
33.71M JPY
Employees
29,297
Market Cap
9.49B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 997.33B | 61.12B | 6.53% |
| Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
| Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
| Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
| Mar 31, 2021 | 730.54B | -66.87B | -8.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 32.03M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.11M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
| REMSleep Holdings | 6.73K |
Olympus News
- 27 days ago - Olympus Corporation (OLYMY) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Olympus Corporation (OLYMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 months ago - Olympus Corporation (OLYMY) Discusses New Strategic Vision and Expansion of Endoscopy-Enabled Care Prepared Remarks Transcript - Seeking Alpha
- 7 months ago - Olympus Corporation (OLYMY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Olympus Corporation (OLYMY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Olympus Corporation (OLYMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Olympus Corporation (OLYMY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Olympus shares drop over 5% after CEO resigns over drug allegation - CNBC